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ABSTRACT
ObjectiveToevaluatetheeffectivenessofhomedelivered
pragmatic rehabilitation—a programme of gradually
increasingactivitydesignedcollaborativelybythepatient
and the therapist—and supportive listening—an
approach based on non-directive counselling—for
patients in primary care with chronic fatigue syndrome/
myalgic encephalomyelitis or encephalitis (CFS/ME).
Design Single blind, randomised, controlled trial.
Setting 186 general practices across the north west of
England between February 2005 and May 2007.
Participants 296 patients aged 18 or over with CFS/ME
(median illness duration seven years) diagnosed using
the Oxford criteria.
Interventions Participants were randomly allocated to
pragmatic rehabilitation, supportive listening, or general
practitioner treatment as usual. Both therapies were
deliveredathomein10sessionsover18weeksbyoneof
three adult specialty general nurses who had received
four months’ training, including supervised practice, in
each of the interventions. GP treatment as usual was
unconstrainedexceptthatpatientswerenottobereferred
for systematic psychological therapies during the
treatment period.
Main outcome measures The primary clinical outcomes
were fatigue and physical functioning at the end of
treatment (20 weeks) and 70 weeks from recruitment
compared with GP treatment as usual. Lower fatigue
scores and higher physical functioning scores denote
better outcomes.
Results A total of 257 (87%) of the 296 patients who
entered the trial were assessed at 70 weeks, the primary
outcome point. Analysis was on an intention to treat
basis, with robust treatment effects estimated after
adjustment for missing data using probability weights.
Immediately after treatment (at 20 weeks), patients
allocated to pragmatic rehabilitation (n=95) had
significantly improved fatigue (effect estimate −1.18,
95%confidenceinterval−2.18to−0.18;P=0.021)butnot
physical functioning (−0.18, 95% CI −5.88 to +5.52;
P=0.950) compared with patients allocated to treatment
as usual (n=100). At one year after finishing treatment
(70 weeks), there were no statistically significant
differences in fatigue or physical functioning between
patients allocated to pragmatic rehabilitation and those
on treatment as usual (−1.00, 95% CI −2.10 to +0.11;
P=0.076 and +2.57, 95% CI 3.90 to +9.03; P=0.435). At
20 weeks, patients allocated to supportive listening
(n=101) had poorer physical functioning than those
allocated to treatment as usual (−7.54, 95% CI −12.76 to
−2.33; P=0.005) and no difference in fatigue. At
70 weeks, patients allocated to supportive listening did
not differ significantly from those allocated to treatment
as usual on either primary outcome.
Conclusions For patients with CFS/ME in primary care,
pragmatic rehabilitation delivered by trained nurse
therapists improves fatigue in the short term compared
with unconstrained GP treatment as usual, but the effect
issmallandnotstatisticallysignificantatoneyearfollow-
up. Supportive listening delivered by trained nurse
therapists is not an effective treatment for CFS/ME.
Trial registration International Standard Randomised
Controlled Trial Number IRCTN74156610.
INTRODUCTION
Patients with chronic fatigue syndrome, also known as
myalgic encephalomyelitis or myalgic encephalitis,
have a principal symptom of fatigue that lasts at least
six months and is of sufficient severity to substantially
impair functioning.
1 Diagnosisis by historyand exclu-
sionofmedicalandpsychiatricreasonsforthefatigue.
2
Chronicfatiguesyndrome/myalgic encephalomyelitis
orencephalitis(CFS/ME)causessubstantialdisability
3
and has important consequences for healthcare use
and expenditure.
45In the United Kingdom, the popu-
lation prevalence of CFS/ME has been estimated at
0.2-0.4%.
6
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ment, either because there are no services in their
area or because they are unable to attend services.
6
The recent National Institute for Health and Clinical
Excellence (NICE) guidelines on CFS/ME
7 state that
the condition should be managed in primary care, but
current evidence about treatment effectiveness comes
fromtrialsinsecondarycare.PatientswithCFS/MEin
primary care differ from those seen in hospital
settings.
8 Treatments for CFS/ME that are effective in
secondarycaremaybelesseffectiveinprimarycare,so
pragmatic trials of treatments for patients in primary
care are needed.
9
Asystematicreviewofcontrolledtrialsoftreatments
forCFS/ME,includingbehavioural,pharmacological,
and complementary approaches, concluded that there
is evidence that cognitive behavioural therapy and
graded exercise therapy are effective.
10 An updated
Cochrane review of cognitive behavioural therapy
for adults with CFS/ME concluded that this approach
is effective at reducing fatigue as assessed at the end of
the treatment period.
11 A Cochrane review of graded
exercise therapy concluded that some patients benefit
from exercise, but that this approach is not always
acceptable to patients.
12 Cognitive behavioural ther-
apy and graded exercise therapy are recommended
in the NICE guidelines, but both treatments need to
be delivered by specialist therapists.
7
In 2001, we reported a new educational self help
treatmentforCFS/MEcalledpragmaticrehabilitation.
This treatment had proved successful in a hospital
based trial, with 57% of patients who received prag-
matic rehabilitation recovering after 12 months com-
pared with 6% of patients in a waiting list control
group.
13Pragmaticrehabilitationhaselementsincom-
mon with cognitive behavioural therapy and graded
exercisetherapy,butdoesnotrequiredeliverybycog-
nitive behavioural therapists or physiotherapists.
Whereas cognitive behavioural therapy usually starts
withanindividualisedformulationofthepatient’spro-
blem(s), pragmatic rehabilitation starts with the more
didacticpresentationofanexplanatorymodelofCFS/
ME,whichprovidestherationaleforagradedincrease
in activity. The pragmatic rehabilitation activity pro-
gramme is devised collaboratively with the patient
rather than prescribed on the basis of exercise testing,
as in graded exercise therapy.
We aimedtodeterminewhetherpragmaticrehabili-
tationdeliveredinprimarycarebygeneralnurseswho
had received training in the technique would be an
effective therapy compared with treatment as usual
by the general practitioner (GP). We added a third
armtoourtrial,supportivelistening,tocontrolforsup-
portive therapist contact time and to allow a compar-
ison with a therapy that is widely available in primary
care.
14 A previous primary care study showed that
counselling was as effective as cognitive behavioural
therapy for a broader group of patients with chronic
fatigue,
15 although counselling based therapies have
not previously been trialled for CFS/ME.
METHODS
The trial was overseen by independent data monitor-
ing and trial steering committees. We previously pub-
lished the protocol for our trial,
16 and report the
methods and findings in accordance with the CON-
SORT guidelines for non-pharmacological trials.
17
Participants
Patients aged 18 or over who fulfilled the Oxford cri-
teria for CFS/ME,
1 scored 70% or less on the SF-36
physical functioning scale,
18 and scored four or more
ontheChalderet alfatiguescale
19wererecruitedfrom
186 general practices across the north west of England
between February 2005 and May 2007. The Oxford
criteria
1 require that patients have a principal com-
plaintoffatigueunexplainedbyothermedicalandpsy-
chiatric conditions. The fatigue must be of definite
onset, affect both physical and mental functioning,
and have been present for more than 50% of the time
over the past six months.
Patientswereexcludediftheyfulfilleddiagnosticcri-
teriaforantisocial,borderline,orparanoidpersonality
disorders,
20hadactivesuicidalideation,wereunableto
read or write English, were currently undertaking sys-
tematic psychological therapies for CFS/ME, or had
received pragmatic rehabilitation in the past year.
GPs referred in accordance with a brief diagnostic
protocol and checklist, which included a list of exclu-
sionary tests.
2
Procedure
Referred patients were sent trial information in the
post,which includedbriefdetails ofall threetreatment
arms, and were telephoned one week later to ascertain
whether they agreed to take part in the trial. Where
patients declined to participate, the reasons for refusal
were recorded. After providing informed consent,
patients were assessed at home and their eligibility
determinedbyaresearchassistant.Eligibilitywascon-
firmed via consultation with clinically qualified mem-
bers of the team if there were any queries about
inclusion or exclusion criteria. Details of eligible
patients were provided by telephone to an indepen-
dent randomisation service within two working days.
Individual patients were randomly allocated to one
of the three treatment arms using computer generated
randomised permuted blocks (with randomly varying
block sizes of 9, 12, 15, and 18), after stratification on
the basis of whether the patient was non-ambulatory
(used a mobility aid on most days) and whether the
patient fulfilled London ME criteria.
21 The London
ME criteria were developed in conjunction withmem-
bers of patient support groups. We stratified partici-
pants according to these criteria to enable us to
address the possibility that people fulfilling London
ME criteria are different from the rest of the sample.
Where applicable, patients were assigned to therapists
in a simple random fashion. The random allocation
was emailed to the trial manager, who assigned each
patient a unique study number and notified the
RESEARCH
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cated to a therapy arm.
Treatments
The pragmatic rehabilitation and supportive listening
treatments consisted of 10 sessions over an 18 week
period. Each programme comprised a 90 minute
home visit on week 1; one hour home visits on weeks
2, 4, 10, and 19; and 30 minute telephone calls on
weeks 3, 6, 8, 12, and 15. We delivered the treatment
inpatients’homestoenableinclusionofmoreseverely
affected patients who might not otherwise access treat-
mentandtoassistwithrecruitmentandretention.Both
facetofaceandtelephonetherapysessionsweretaped.
Patientsinthepragmaticrehabilitationandsupportive
listening arms were free to consult their GP during the
course of treatment. The treatments are described in
our protocol
16 and in table 1.
Training and supervision of therapists
Therapywasdeliveredbythreeregistered,adultspeci-
alty, general nurses who had worked in primary care
but had no previous experience of CFS/ME. All three
nurses delivered both pragmatic rehabilitation and
supportive listening. Four months of training in each
intervention was provided over a six month period
(box), with a period of two months when both inter-
ventions were taught and practised in parallel (with
fourvolunteerpatientspertherapy).Trainingforprag-
matic rehabilitation was provided by members of the
trial team (members of the trial team (RPB, RKM, SP,
AJW,CD,andCCG)andPaulinePowell,amemberof
the Fatigue Intervention by Nurses Evaluation (FINE)
trial group), and training for supportive listening was
provided by experienced counsellors (Diana Jerman,
counselling trainer, and David Quarmby, counselling
supervisor, both members of the FINE trial group).
Fortnightly group and individual supervision was
provided while the therapists were treating patients.
Supervision for pragmatic rehabilitation was provided
in group meetings held approximately fortnightly by
RKM, a psychiatrist with extensive experience of
treating CFS/ME, and supplemented by occasional
individual supervision sessions by RPB, a clinical psy-
chologist, experienced cognitive behavioural thera-
pist, and one of the people who designed the original
intervention in secondary care. Supervision for sup-
portive listening was provided in meetings held
approximately fortnightly individually by DQ and
supplemented by occasional group supervision meet-
ings (DQ and DJ, both qualified and experienced
counsellors).
Assessment of treatment fidelity and quality
Treatment fidelity and quality were assessed during
discussion of individual cases and, in the case of prag-
matic rehabilitation, with frequent reference to the
pragmatic rehabilitation manual. Additionally, 85
tapes of face to face therapy sessions from 21 patients
(11 receiving pragmatic rehabilitation and 10 on sup-
portive listening) were selected at random from early
and late stages of the trial. Sessions were rated for fide-
lityandqualitybyfiveraters,allofwhomwereblindto
treatment allocation. Four of the five raters were
Table 1 |Description and summary of treatments
Pragmatic rehabilitation Supportive listening
General practitioner treatment
as usual
Overview
A programme of graded return to activity is designed
collaboratively by the patient and the therapist on the basis of a
physiological dysregulation model of CFS/ME. A listening therapy based on non-directive counselling in which
the therapist aims to provide an empathic and validating
environmentin which the patientcan discuss hisor her concerns
and work towards resolution of whichever problems the patient
wishes to prioritise.
GPs were asked to manage their
cases as they saw fit, but not to
refer for systematic psychological
therapies for CFS/ME during the
18 week treatment period.
The rehabilitation programme encourages patients to regularise
their sleep patterns and includes relaxation exercises to address
the somatic symptoms of anxiety.
Weadded a furthercomponentto address the concentrationand
memory problems that many patients experience.
29
Structure of
treatment
Session1 Patientswerepresented witha detailed explanationof
their symptoms, supported by a referenced manual with diary
pages.
Session 1 The basis of the therapeutic approach was explained
and a short booklet with diary pages givento patients. Issues for
discussion in subsequent sessions were elicited, and the
therapists used standard counselling techniques of active
listening, reflection, and summarisingtoensure thatpatients felt
understood.
Session 2 The manual was reviewed, patient priorities were
determined,andgoalsforrehabilitationsetcollaborativelybythe
patientandtherapist.Carewastakentosetgoalsataleveleasily
manageable by the patient.
Sessions 2-10 The therapist summarised the previous session’s
work and invited the patient to set the agenda for that session’s
discussion. The therapists did not provide any explanation for
patients’ symptoms. Throughout, the content of sessions was
determined by patients; therapists avoided giving advice or
leading patients, and concentrated on providing an empathic,
validating environment in which patients could discuss their
concerns.
Sessions 3-10 Progress was reviewed and the rehabilitative
programme adjusted if necessary.
Sessions5-10Relapsepreventionwasdiscussed.Inallsessions,
the model of CFS/ME contained in the manual was reinforced.
CFS/ME, chronic fatigue syndrome/myalgic encephalomyelitis or encephalitis; GP, general practitioner.
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 3 of 12independent of the trial. Raters were given a brief,
point by point description of each treatment and
asked to use this information to determine which
treatment had been delivered. They were then asked
to judge the extent to which the essential components
of the treatments had been delivered by using a set of
Outline of training sessions provided to FINE nurse therapists
Introduction (2 hour sessions)
Induction.
Understanding CFS/ME, reading lists.
How to read research papers.
Randomised controlled trials, ethical issues, informed consent.
The structure of the FINE trial.
Pragmatic rehabilitation training (half day sessions, delivered approximately weekly)
Overview of therapy and outcomes. The pragmatic rehabilitation model and the importanceo fp r o v i d i n grationales.
Deconditioning: the physiology.
Deconditioning: the rationale for treatment, designing an activity programme, and goal setting.
Sleep, cortisol, circadian rhythms: the physiology.
Sleep, cortisol, circadian rhythms: the rationale for treatment, regularising sleep patterns, and goal setting.
Anxiety: the physiology.
Anxiety: the rationale for treatment, learning to relax, and goal setting.
Shadowing group delivery of pragmatic rehabilitation in a hospital over eight weeks.
The structure of treatment—how to use the visits and phone calls. Delivering the rationale. Agenda setting.
Overcoming impediments to change.
Using techniques from motivational interviewing.
Psychosocial issues—h e l p i n gp e o p l et ol o o kt ot h ef u t u r e ,t e r m i n a t i o no ft h e r a p y .
Summary, overview and getting ready to start working with practice patients. Supervision contracts.
Rehabilitation issues (back to work).
Practice patients started. Pragmatic rehabilitation supervision sessions (group and individual) started.
Relapse prevention
Follow up 1—Learning from practice.
Follow up 2—Learning from practice.
Supportive listening training (half day sessions, delivered approximately weekly)
Introduction to supportive listening, diary keeping, confidentiality, codes of conduct, and use of supervision.
Background to person centred listening, core conditions, and listening skills. What counselling is not.
Qualities of the listener. Beginning therapy, engagement, and the patient’s frame of reference. Stages of the listening
relationship.
Helping the patient to tell a story. Attending and listening, body language, and non-verbal messages. Reflecting back.
Open questions and role plays.
Films/discussion. Skills exercises (for example, using silence). Barriers to listening. Directed reading.
Group discussion of learning and insights. Challenge and specificity. Skills practice.
Practice patients started. Supportive listening supervision sessions started.
Creating an emotional and physical environment conducive to the helping relationship.
Telephone counselling skills.
Telephone counselling skills—review and practice.
Review of progress, identification of further training needs.
Group work. Taking action. Endings.
Endings. Listening skills practice.
Follow up 1—Reviewing practice. Boundaries.
Follow up 2—Reviewing practice. Transference issues.
Trainingsessions used a mixture ofpresentations by the trainers, discussion, group activities,role play, videos, and review of case material. Reading lists were given.
Homework was set insome sessions and reviewedat the next session.
CFS/ME, chronic fatigue syndrome/myalgic encephalomyelitis orencephalitis; FINE,Fatigue Intervention by Nurses Evaluation.
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wereaskedtomakea judgmentonthe qualityofdeliv-
ery of the components.
Assessments and outcomes
Patientswereassessedatentrytothetrial(week0),after
treatment (week 20), and one year after finishing treat-
ment (70 weeks from recruitment). Assessments were
performed by trained researchers blind to treatment
allocation; any unblindings were recorded. The asses-
sors were trained by an academic psychiatrist (RKM)
who has many years’ experience of using the screening
interview.Trainingincludedtheuseofvideosandprac-
tice rating sessions. Further training was provided mid-
way through the trial to ensure continued competence.
Baselineassessmentincludedapsychiatricscreening
interview to screen for personality disorders and to
determine anxiety and depression diagnoses (but not
other psychiatric diagnoses),
22 and recording of medi-
calcomorbidities.Participants’postcodeswereusedto
obtain a measure of the relative social environment in
which they lived (Townsend deprivation index
scores).
23
Primary clinical outcomes were percentage scores
ontheSF-36physicalfunctioningscale,
18wherehigher
scores indicate better outcomes, and on the 11 item
Chalder et al fatigue scale,
19 where lower scores indi-
cate better outcomes. Each item on the fatigue scale
was scored dichotomously on a four point scale (0, 0,
1,or1);totalscoresoffourormoreonthefatiguescale
designate clinically significant levels of fatigue.
Secondary outcomes were anxiety and depression,
asmeasuredbytheanxietyanddepressionsubscalesof
the hospital anxiety and depression scales (HADS;
lower scores indicate better outcomes),
24 and level of
sleepproblems,asmeasuredbyscoresonthefouritem
Jenkins et al sleep scale (lower scores indicate better
outcomes).
25 Our assessment also included a full eco-
nomic evaluation of the relative cost effectiveness of
pragmatic rehabilitation and supportive listening
when compared with treatment as usual, the results of
which will be reported separately.
Statistical analysis
We aimed to recruit 360 patients, a figure based on an
estimated 20 percentage point difference in improve-
mentratebetweenthepragmaticrehabilitationandthe
GP treatment as usual arms (50% improvement versus
30% improvement). A sample of this size would give
80% power with a two sided significance level of
P=0.05andallowforlosstofollow-upof23%.Inaccor-
dance with our protocol, “improvement” was defined
asscoringlessthanfouronthefatiguescaleorimprov-
ingby 50%ormore orscoring75%or moreontheSF-
36physicalfunctioningscale.
16Werevisedourrecruit-
ment target to 288 in September 2006 when it became
clearthatourlosstofollow-upwaslessthananticipated
(13% at 70 weeks).
Data were analysed in accordance with our analysis
plan
16 and the CONSORT guidelines,
17 with between
group comparisons analysed on an intention to treat
basis.Analysisofcovariancewasusedtoallowforstra-
tification by ambulatory status and London ME cri-
teria. The baseline value of the relevant outcome
measure was entered as a covariate. Firstly, a global
test of equality of the three groups was undertaken for
each outcome measure in a complete case analysis. If
the groups differed, pragmatic rehabilitation was com-
paredwithsupportivelistening.Secondly,ifpragmatic
rehabilitation and supportive listening were equiva-
lent, both approaches were compared with GP treat-
ment as usual. If pragmatic rehabilitation and
supportive listening differed, they were compared
individually with GP treatment as usual.
The final analyses involved generating both robust
standard errors and corresponding confidence inter-
vals for the treatment effect estimates, together with
weighting adjustments to allow for missing
outcomes.
2627 Potential biases in treatment effect esti-
mates arising from missing outcome data were investi-
gated using inverse probability weighting.
2627 This
assumes that the mechanism for missing data is ignor-
able—that is, data are missing at random.
28 Standard
errors and 95% confidence intervals for parameters
were calculated using robust (sandwich) estimators,
allowing for the effects of the inverse probability
weights and possible skewness (lack of normality) of
the outcome data.
All formal analyses were carried out using Stata
version 9.
RESULTS
Participants
Atotalof449patientswerereferredtothetrialbytheir
GPs; 78 (17%) declined to be assessed, 15 (3%) were
erroneous referrals, and 18 (4%) were ineligible for
assessment. Thus 338 patients underwent baseline
assessment, after which 42 (12.4%) were excluded,
leaving 296 patients to be randomised. Participant
flow through the trial, including allocation to thera-
pists, is shown in figure 1.
Three quarters (230/296 (78%)) of our sample were
female. The mean age was 44.6 years (SD 11.4). The
median illness duration was 7 years (range 0.5-51.
7 years, interquartile range 3.2-12.3). Thirty three
patients(11%)werenon-ambulatory,and92(31%)ful-
filled London ME criteria. Townsend deprivation
scores ranged from −7 to 13. Eighty eight (29.7%)
patients had any anxiety and/or any depression diag-
nosis. Seventy four patients (25%) had one self
reported medical comorbidity that did not explain
their fatigue, and 108 patients (36.5%) had two or
more comorbidities. The top three categories of med-
ical comorbidity were musculoskeletal disorders (63/
296 (21.3%)), gastrointestinal problems including irri-
table bowel syndrome (45/296 (5.2%)), and cardio-
vascular diseases such as hypercholesterolaemia (41/
296 (13.9%)).
Descriptive statistics for patients allocated to each
treatment arm can be seen in table 2. In accordance
with our analysis plan, we did not evaluate differences
RESEARCH
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Assessed for eligibility (n=338)
Randomised (n=296)
Patients allocated to therapist one (n=35/95)
  Received intervention (n=35/35)
Patients allocated to therapist two (n=31/95)
  Received intervention (n=29/31)
Patients allocated to therapist three (n=29/95)
  Received intervention (n=28/29)
Patients allocated to therapist one (n=31/101)
  Received intervention (n=26/31)
Patients allocated to therapist two (n=35/101)
  Received intervention (n=33/35)
Patients allocated to therapist three (n=35/101)
  Received intervention (n=32/35)
Number of general practices
providing treatment as usual (n=84)
Completed intervention (n=80/95)
Discontinued intervention (n=12/92):
  Unhappy with randomisation (n=4)
  Too busy (n=3)
  Not benefiting or feeling worse (n=2)
  Lost contact or no reason (n=2)
  Nurse therapist safety concern (n=1)
Completed intervention (n=84/101)
Discontinued intervention (n=7/91):
  Not benefiting or feeling worse (n=3)
  Nurse therapist safety concern (n=1)
  Too busy (n=1)
  Misdiagnosis (n=1)§
  Received different treatment (n=1)*
Completed intervention (n=100/100)
Discontinued intervention (n=0)
Completed assessment at 20 weeks (n=85/95):
  Completed intervention (n=77/80)
  Didn’t start or complete intervention (n=8/15)
Lost to follow-up (n=10/95):
    Declined (n=5)
    No response (n=4)
    Researcher safety concern (n=1)
Completed assessment at 20 weeks (n=97/101):
  Completed intervention (n=84/84)
  Didn’t start or complete intervention (n=13/17)
Lost to follow-up (n=4/101):
    No response (n=3)
    Researcher safety concern (n=1)
Completed assessment at 20 weeks (n=92/100)
Lost to follow-up (n=8/100):
    Declined (n=5)
    No response (n=2)
    Patient admitted to hospital (n=1)
Completed assessment at 70 weeks (n=81/95):
  Completed intervention (n=77/80)
  Didn’t start or complete intervention (n=4/15)
Lost to follow-up (n=14/95):
    Declined (n=10)
    No response (n=3)
   Researcher safety concern (n=1)
Completed assessment at 70 weeks (n=90/101):
  Completed intervention (n=80/84)
  Didn’t start or complete intervention (n=10/17)
Lost to follow-up (n=11/101):
    Declined (n=6)
    No response (n=4)
    Researcher safety concern (n=1)
Completed assessment at 70 weeks (n=86/100)
Lost to follow-up (n=14/100):
    Declined (n=8)
    No response (n=6)
Pragmatic rehabilitation (n=95)*:
  Received intervention (n=92)
  Did not receive intervention (n=3):
    Unhappy with randomisation (n=2)
    Lost contact (n=1)
Supportive listening (n=101)†‡:
  Received intervention (n=91)
  Did not receive intervention (n=10): 
    Lost contact (n=5)
    Too busy (n=3)
    Unhappy with randomisation (n=2)
General practitioner treatment as usual
  (n=100):
    Received intervention (n=100)
Not assessed (n=111):
  Ineligible for assessment (n=18):
    No longer fatigued (n=5)
    Medical reasons for symptoms (n=6)
    Exclusionary CFS/ME treatment (n=7)
  Incorrect referral (for example, wrong identity, administrative errors in referral details) (n=15)
  Declined to be assessed (n=78):
    No reason given (n=24)
    Conflicting demands (for example, work, family) (n=16)
    Disagreed with treatment approaches (n=13)
    Too ill to take part (n=11)
    Did not want to be randomised (n=9)
    Happy with current treatment (n=5)
Excluded (n=42):
  Did not meet Oxford criteria (n=25)
  Did not meet SF-36 criteria (n=13)
  Currently having pragmatic rehabilitation treatment (n=2)
  Unable to complete assessment without interpreter (n=2)
  Declined to participate after assessment (n=0)
Fig 1 | CONSORT diagram showing patient flow through the trial. *One patient randomised to pragmatic rehabilitation was
treated by a therapist other than the one to whom she was randomised. †One patient originally randomised to supportive
listening was treated with pragmatic rehabilitation, and by a different therapist from the one originally randomised, because
another person living at the same address was receiving pragmatic rehabilitation in the trial. ‡One patient randomised to
supportive listening was admitted to the trial with an SF-36 score of 75% and completed the trial. §One patient randomised to
supportive listening subsequently received a diagnosis of multiple sclerosis and withdrew from treatment. CFS/ME, chronic
fatigue syndrome/myalgic encephalomyelitis or encephalitis
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Treatment delivered
The mean number of sessions delivered was 9.63 (SD
0.88)forpatientswhocompletedpragmaticrehabilita-
tion treatment and 9.5 (0.83) for those receiving sup-
portivelistening.Accordingtopatientreports,patients
allocated to general practice treatment as usual had a
median of three (range 0-16) consultations with their
GPs during the 18 week treatment period, compared
with two (0-14) for the pragmatic rehabilitation group
and three (0-23) in the supportive listening group. The
median number of visits to practice nurses were 0
(range 0-22) for patients allocated to GP treatment as
usual, 0 (0-4) for those receiving pragmatic rehabilita-
tion, and 0 (0-5) for those on supportive listening.
From patient reports at baseline, 264 (89%) of the
296 patients reported having received medication in
the past six months. A total of 160 patients (54%) had
been prescribed antidepressants; 49 of whom were
receiving GP treatment as usual (49% of the GP treat-
mentasusualgroup),51ofwhomwerereceivingprag-
matic rehabilitation (54% of that group), and 60 of
whom were on supportive listening (59% of that
group). Seventy nine (27%) patients had been pre-
scribed analgesics; 27 of whom were undergoing GP
treatment as usual (27% of the GP treatment as usual
group), 30 who were receiving pragmatic rehabilita-
tion (32% of that group), and 22 who were receiving
supportive listening (22% of that group).
29
Treatment fidelity
Weachievedhightreatmentfidelity—thatis,nearlyall
sessions were congruent with the predefined structure
and content of each therapy. Blind raters correctly
identified 42 (100%) of the 42 pragmatic rehabilitation
sessions and 40 (93%) of the 43 supportive listening
sessions. Sessions were rated for quality on a 7 point
scale from 1 (unacceptable) to 7 (excellent). The mean
ratings were 5.24 for pragmatic rehabilitation (SD
0.93) and 4.4 for supportive listening (0.98). There
were no significant between therapist differences on
quality ratings for either therapy.
Preliminary analysis to deal with missing data
Preliminary analysis indicated that the main predictor
of failure to provide follow-up data was whether the
participant withdrew from treatment (not applicable
Table 2 |Demographic and baseline characteristics of participants
Pragmatic rehabilitation
(n=95)
Supportive listening
(n=101)
General practitioner
treatment as usual
(n=100)
Female 74 (77.9) 80 (79.2) 76 (76.0)
Ambulatory 85 (89.5) 88 (87.1) 88 (88.0)
Met London ME criteria 28 (29.5) 31 (30.7) 33 (33.0)
Any anxiety diagnosis 21 (26.6) 17 (20.0) 22 (25.6)
Any depression diagnosis 18 (18.9) 15 (14.9) 20 (20.0)
Self reported medical comorbidities
0 42 (44.2) 39 (38.6) 33 (33.0)
1 21 (22.1) 29 (28.7) 24 (24.0)
2 or more 32 (33.7) 33 (32.7) 43 (43.0)
Ageinyears(mean(range)) 43.74 (18–68) 45.13 (21–68) 44.92 (18–71)
Townsend deprivation
score (median (range))
1.5 (−6–13) 0 (−7–13) 0.5 (−7–13)
Values are numbers (percentages) unless otherwise indicated.
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Fig 2 | Mean scores on the Chalder et al fatigue scale, SF-36 physical functioning scale, Jenkins et al sleep scale, and the
hospital anxiety and depression scales (HADS) depression subscale at baseline (week 0), after treatment (week 20), and at one
year follow-up (week 70) for patients allocated to the three treatment arms. *Significant difference between PR and GPTAU;
†significant difference between SL and GPTAU, P<0.05 for both. GPTAU, general practitioner treatment as usual; PR, pragmatic
rehabilitation; SL, supportive listening
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to adjust for these missing data were, therefore, calcu-
lated separately for participants who completed ther-
apy and those who withdrew from treatment in both
the pragmatic rehabilitation and supportive listening
arms. A single weight was calculated for the GP treat-
ment as usual arm. The adjustment weights are simply
thereciprocaloftheproportionofrelevantparticipants
who provided an observed outcome.
Outcomes
Descriptivestatisticsfortheoutcomemeasuresatbase-
line,20weeks,and70weeksareshownintable 3.Our
pre-designated primary outcome point was 70 weeks,
which we chose because we wanted to assess the
long term effectiveness of pragmatic rehabilitation.
16
In the initial unweighted (complete case) analysis at
20weeks,globaltestsofequalityandcontrastsshowed
between group differences in fatigue (F2268=4.49;
P=0.012), physical functioning (F2267=5.36; P=0.005),
depression (F2268=5.03; P=0.007), and sleep
(F2266=5.99; P=0.003). In all of these cases, patients
allocated to pragmatic rehabilitation did significantly
better than those receiving supportive listening (fig 2).
The final 20 week analyses involved both robust
standard errors and corresponding confidence inter-
vals, together with weighting adjustments to allow for
missing outcomes. Compared with patients allocated
to GP treatment as usual, patients allocated to prag-
maticrehabilitationhadsignificantlyimprovedfatigue
(treatment effect estimate −1.18, 95% CI −2.18 to
−0.18; P=0.021), depression (−1.18, −2.16 to −0.20;
P=0.018),andsleep(−1.54,−2.96to−0.11;P=0.035)at
20 weeks. Patients who received supportive listening
had significantly worse physical functioning at
20 weeks than patients who had treatment as usual
(−7.54,−12.76to−2.33;P=0.005);supportivelistening
had little effect on fatigue, anxiety, depression, or
sleep. Estimated differences between the outcomes of
pragmatic rehabilitation and GP treatment as usual,
and between those of supportive listening and GP
treatment as usual, are shown in table 4.
A total of 257 (87%) of the 296 patients who entered
the trial were assessed at 70 weeks. In the initial
unweighted (complete case) analysis at 70 weeks, glo-
bal tests and contrasts showed a between group differ-
ence in physical functioning only (F2,249=3.37;
P=0.036). In the final weighted analysis at 70 weeks,
patients allocated to pragmatic rehabilitation did not
differ significantly in physical functioning from those
allocated to GP treatment as usual (effect +2.57, 95%
CI −3.90 to +9.03; P=0.435; table 4). The treatment
differenceintermsoffatiguewasnolongerstatistically
significant at 70 weeks (−1.00, −2.10 to +0.11;
P=0.076), although much of the improvement in the
pragmatic rehabilitation group seen at 20 weeks
appeared to be maintained. Supportive listening did
not differ significantly from GP treatment as usual on
any of the outcomes at 70 weeks.
At70weeks,11patientsallocatedtopragmaticreha-
bilitation (14%) and six patients (7%) allocated to GP
treatment as usual were no longer classified as cases of
fatigue(thatis,scoredlessthan4onthefatiguescale).A
total of 17 patients allocated to pragmatic
Table 3 |Mean (SD) scores at baseline, 20 weeks, and 70 weeks on the Chalder et al fatigue scale, the SF-36 physical
functioning scale, the Jenkins et al sleep scale, and the hospital anxiety and depression scales (HADS)
Pragmatic rehabilitation Supportive listening General practitioner treatment as usual
n Mean SD n Mean SD n Mean SD
Chalder et al fatigue scale (11 items)*
Baseline 95 10.49 1.12 101 10.52 1.03 100 10.34 1.17
20 weeks 85 8.39 3.67 97 9.67 2.76 92 9.32 3.18
70 weeks 81 8.72 3.65 90 9.39 3.21 86 9.48 2.71
SF-36 physical functioning scale (%)† †
Baseline 95 29.84 17.86 101 30.64 19.04 100 29.80 19.63
20 weeks 85 39.94 25.21 96 33.28 22.94 92 40.27 26.45
70 weeks 81 43.27 27.38 90 35.72 25.94 86 39.83 27.77
Jenkins et al sleep scale (four items)*
Baseline 95 14.11 4.88 101 14.30 4.75 100 12.85 4.96
20 weeks 83 11.31 5.27 97 13.77 5.29 92 12.17 5.59
70 weeks 81 12.32 5.61 90 13.18 5.71 86 12.63 5.34
HADS anxiety scale (seven items)*
Baseline 95 11.02 4.77 101 10.80 5.12 100 9.65 5.06
20 weeks 85 9.04 4.51 97 9.52 4.93 92 8.63 5.06
70 weeks 81 9.54 4.70 90 9.62 4.87 85 8.89 5.40
HADS depression scale (seven items)*
Baseline 95 9.67 4.08 101 9.73 4.07 100 9.26 4.25
20 weeks 85 7.28 4.02 97 8.85 4.01 92 8.48 4.47
70 weeks 81 7.88 4.45 90 8.67 4.51 85 8.06 4.75
*Lower scores indicate better outcomes.
†Higher scores indicate better outcomes.
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improved on the physical functioning scale (that is,
had scores of >70%, or had improved by 50% from
baseline),
16 compared with 10 patients (12%) allocated
to GP treatment as usual.
Safety of treatment
Onepatientdevelopedaherpessimplexinfectiondur-
ing the treatment. During the follow-up period, one
patient attempted suicide, one developed a bleeding
peptic ulcer, and one had a recurrence of cancer. Our
independentdatamonitoringcommitteewasinformed
ofalltheseeventsandconsideredthemunrelatedtothe
trial treatments.
DISCUSSION
We report on the largest primary care treatment trial
for CFS/ME to date, which has a broad and inclusive
sample of patients with a range of levels of disability.
Our study shows that, when compared with treatment
as usual, pragmatic rehabilitation has a statistically sig-
nificant but clinically modest beneficial effect on fati-
gue at the end oftreatment(20weeks), which ismostly
maintainedbutnolongerstatisticallysignificantatone
year after finishing treatment (70 weeks). Pragmatic
rehabilitation did not significantly improve our other
primary outcome, physical functioning, at either
20 weeks or 70 weeks. Improvements in sleep at
20 weeks were considerablysmallerand no longersta-
tistically significant at 70 weeks, and improvements in
depression at 20 weeks were no longer observed at
70 weeks. Pragmatic rehabilitation did not have an
effect on anxiety.
When compared with GP treatment as usual at
20 weeks,supportivelisteninghad no significant effect
on fatigue, anxiety, depression, or sleep. Supportive
listening did have a significant effect on physical func-
tioning,however,withpatientsallocatedtosupportive
listeninghavingworse scores.At 70 weeks,supportive
listening did not differ from GP treatment as usual on
any of the outcomes.
Pragmatic rehabilitation
Our first conclusion is that pragmatic rehabilitation
improved fatigue, sleep, and depression while treat-
ment was ongoing, but that the effects were no longer
statistically significant at follow-up. Pragmatic rehabi-
litation was less effective in our trial than in a previous
secondary care trial,
13 and the proportions of patients
who had recovered in terms of fatigue and physical
functioning scores at 70 weeks were smaller. We sug-
gestfivepossiblereasonswhypragmaticrehabilitation
was not as effective in our trial as in the earlier second-
ary care trial.
Firstly, the characteristics of the patients in the two
trials differ. Our patients were on average eight years
older than those in the earlier trial. The mean illness
durationinourtrial(84months)wasalmostthreeyears
longer than that in the earlier trial (52 months), and
some patients in our study had very long illness dura-
tions. The mean baseline physical functioning scores
among our patients (~30%) were similar to those
reported in the previous trial (~16 on a 10-30 scale).
We succeeded in our aim of including more severely
affected patients, however, meaning that our sample
was heterogeneous with regard to disease severity
and contained patients from across the spectrum of
severity. For example, 11% of patients in our trial
were non-ambulatory and would have been excluded
from a secondary care trial.
Secondly, ours was a pragmatic trial, and we were
broadandinclusiveintheapplicationofourtrialinclu-
sion criteria. For example, we did not require that
Table 4 |Robust treatment effect estimates (compared with general practitioner treatment as
usual) at 20 weeks and 70 weeks on the Chalder et al fatigue scale, the SF-36 physical
functioning scale, the Jenkins et al sleep scale, and the hospital anxiety and depression
scales (HADS)
Effect estimate
95% confidence
interval Standard error P value
Chalder et al fatigue scale (11 items)*
20 weeks
Pragmatic rehabilitation −1.18 −2.18 to −0.18 0.51 0.021†
Supportive listening +0.19 −0.67 to +1.05 0.44 0.663
70 weeks
Pragmatic rehabilitation −1.00 −2.10 to +0.11 0.56 0.076
Supportive listening −0.32 −1.24 to +0.60 0.47 0.497
SF-36 physical functioning scale (%)‡ ‡
20 weeks
Pragmatic rehabilitation −0.18 −5.88 to +5.52 2.90 0.950
Supportive listening −7.54 −12.76 to −2.33 2.65 0.005§
70 weeks
Pragmatic rehabilitation +2.57 −3.90 to +9.03 3.28 0.435
Supportive listening −4.87 −10.74 to +0.99 2.98 0.103
Jenkins et al sleep scale (four items)*
20 weeks
Pragmatic rehabilitation −1.54 −2.96 to −0.11 0.72 0.035†
Supportive listening +0.70 −0.61 to +2.02 0.67 0.295
70 weeks
Pragmatic rehabilitation −1.07 −2.45 to +0.32) 0.70 0.131
Supportive listening −0.32 −1.67 to +1.03 0.68 0.638
HADS anxiety scale (seven items)*
20 weeks
Pragmatic rehabilitation −0.33 −1.39 to +0.72 0.54 0.536
Supportive listening +0.08 −0.93 to +1.08 0.51 0.881
70 weeks
Pragmatic rehabilitation +0.07 −1.18 to +1.33 0.64 0.907
Supportive listening +0.10 −1.05 to +1.25 0.58 0.862
HADS depression scale (seven items)*
20 weeks
Pragmatic rehabilitation −1.18 −2.16 to −0.20 0.50 0.018†
Supportive listening +0.26 −0.73 to +1.26 0.50 0.597
70 weeks
Pragmatic rehabilitation −0.28 −1.41 to +0.85 0.57 0.629
Supportive listening +0.43 −0.74 to +1.61 0.60 0.469
*Lower scores indicate better outcomes.
†P≤0.05.
‡Higher scores indicate better outcomes.
§P≤0.005.
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sionorsleepproblemsinordertoenterourtrial,unlike
in a previousstudy.
30We included complexcases with
medical or psychiatric comorbidities (which we
report), as long as these disorders did not explain the
fatigue.Tenparticipantsinthetrial,includingfourallo-
catedtothepragmaticrehabilitationarm,hadreceived
pragmatic rehabilitation more than one year before
entering our trial but still had CFS/ME, so may have
beenparticularlydifficulttotreat.Althoughourprofile
of scores on the hospital anxiety and depression scales
is similar to that in another UK primary care sample,
31
illness duration was longer in our study and we
includedasubstantialnumberofpatientswithmedical
comorbidities, which may have complicated treat-
ment. The latter are rarely reported in clinical trials,
making a comparison of samples difficult. Future stu-
dies or analyses may examine the impact of comorbi-
dites, level of disability, and chronicity on patient
response to pragmatic rehabilitation treatment.
Thirdly, in the secondary care trial of pragmatic
rehabilitation,
13 the therapy was delivered by an
experienced counsellor who had developed the prag-
matic rehabilitation treatment. In our trial, pragmatic
rehabilitation was delivered by three general nurses
who had no previous experience of either counselling
ordeliveringstructuredtherapies.Thenursesreceived
four months of training so had learned the therapy
ratherthandevelopedit.Althoughourtherapyquality
ratings showed our therapists to be competent, they
were not as experienced at delivering the therapy as
was the practitioner in the previous trial. Additionally,
the nurses were treating a heterogeneous sample and
had to deal with a wide range of patient functioning.
The evidence as to whether inexperienced therapists
can successfully treat CFS/ME is limited: a recent
benchmarkingstudysuggeststheycan,
32butthattreat-
ment effects are generally larger with more experi-
enced therapists. It is possible that the more complex
and difficult cases of CFS/ME can only be treated suc-
cessfully by experienced therapists.
Fourthly, although delivering the treatment in
patients’ homes enabled us to reach more patients
than if the therapy had been delivered in a healthcare
setting, this approach may be non-optimal. Our nurse
therapists encountered various social barriers to treat-
ment in patients’ homes, such as family and financial
problems, and lack of privacy. It is possible that
patients with social problems are screened out in sec-
ondary care studies, or that social problems are dealt
with before referrals are made or patients are accepted
for treatment. It is also possible that delivering treat-
ment in patients’ homes subtly changes the relation-
ship between patients and therapists so that patients
are less likely to adhere to the pragmatic rehabilitation
programme when at home than when in a hospital
setting.
Finally, our treatment period may have been too
short for patients with long illness durations,and treat-
ment effects may have been enhanced had we been
able to provide post-treatment booster sessions. We
chosethedurationoftreatmentonpragmaticgrounds,
taking into account the feasibility of reproducing the
treatment programme in primary care services.
One reason for conducting our trial was to see
whether registered adult specialty general nurses
could be trained to deliver pragmatic rehabilitation.
Our findings suggest that they could, but that despite
an intensive four month training period and ongoing
supervision, pragmatic rehabilitation treatment was
not as effective as when delivered by a highly experi-
enced therapist in secondary care. Furthermore, our
therapists had a high frequency of supervision which
might not be reproducible in non-trial contexts, and
would be difficult to commission.
Supportive listening
Thefinding that supportivelisteningis not aneffective
treatment for CFS/ME in primary care is important,
because treatments similar to supportive listening are
commonly available in primary care and patients for
whomnoothertreatmentisavailablemightbereferred
to them. Contrary to our expectations, supportive lis-
teningdidnotimproveanyofouroutcomes,including
anxiety and depression.
Ridsdale et al showed that counselling was as effec-
tive as cognitive behavioural therapy for chronic fati-
gue in primary care.
15 Only a quarter of the patients in
Ridsdale and colleagues’ study had CFS/ME, how-
ever, and the duration of fatigue was shorter than in
our study (median illness duration 38 months com-
pared with 84 months in our trial). Furthermore, the
trial did not have a treatment as usual control group
and the counselling treatment may not have been as
non-directive as ours.
Oneinterpretationofourfindingsisthatforpatients
with CFS/ME of long duration or for patients with a
severe presentation, supportive listening may actually
distract patients from efforts at rehabilitation by pro-
viding a forum to consider a range of issues of impor-
tance to the patient rather than focusing on
rehabilitation. This may also be one explanation why
supportgroups,evenifvaluedbypatients,arenotasso-
ciated with improvements in fatigue or physical
functioning.
33
Strengths and limitations
In addition to being a large, inclusive, pragmatic, pri-
mary care trial, our study had other strengths. We
trained general nurses to deliver the therapy, thus
increasing the generalisability of our findings. Using
all three nurse therapists to deliver both treatments
allowed us to determine the effectiveness of the thera-
pies rather than the therapists, and the random alloca-
tion of patients to therapists will enable us to examine
therapist effects in a future analysis. Our nurse thera-
pists achieved high treatment fidelity and the delivery
of the two treatments was of comparable quality. We
hadlowdropoutrates,andhighratesoffollow-up.The
interpretation of our findings is aided by the inclusion
of both a comparison arm (supportive listening) and a
treatment as usual control arm.
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accurate indication of the effectiveness of nurse deliv-
ered pragmatic rehabilitation and supportive listening
for CFS/ME in primary care. The difference between
the findings of this trial and those of our previous trial
in secondary care
13 provides evidence that treatment
approaches shown to be effective in randomised con-
trolledtrialsinhospitalbasedoutpatientclinicsmaybe
lesseffectiveforpatientsinthecommunitywithlonger
durations of illness.
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Conclusions and further research
Pragmatic rehabilitation delivered at home by trained
general nurses over a period of 18 weeks improved
fatigue, sleep, and depression among patients with
CFS/ME, but these effects were not maintained in the
long term once treatment was completed. Supportive
listening delivered by trained general nurses was not
an effective treatment for CFS/ME in primary care.
Morestudiesareneededtodeterminetheoptimalcon-
ditions under which pragmatic rehabilitation can be
delivered to patients in the community with CFS/ME
andwhetherthelimitedbenefitsseeninthistrialcanbe
sustained.
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